Welcome to Medical News Today

Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current list) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.

Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.

By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our rights request form. Learn more in our Privacy Policy.

Please accept our privacy terms

We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our Advertising Policy and Privacy Policy. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.

Get the MNT newsletter

Email an article

You have chosen to share the following article:

How elderberries can help you fight the flu

To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don't include any URLs in your comments, as they will be removed upon submission.

We do not store details you enter into this form. Please see our privacy policy for more information.

How night shifts can increase cancer risk

Working night shifts disrupts the body's circadian rhythm, which a number of studies have found may raise the risk of cancer development. Now, researchers have shed light on the mechanisms behind this association.

Researchers have shed light on how shift work may increase cancer risk.

Scientists from the Massachusetts Institute of Technology (MIT) reveal that disruption to the circadian rhythm also leads to the impairment of two tumor suppressor genes, which can spur tumor growth.

Lead author Thales Papagiannakopoulos, of MIT's Koch Institute for Integrative Cancer Research, and colleagues publish their findings in the journal Cell Metabolism.

Around 15 million people in the United States work night shifts or other irregular schedules, which studies have shown may have negative implications for health.

A study reported by Medical News Today last year, for example, found a link between rotating night shift work and increased risk of death from cardiovascular disease, lung cancer, and all causes.

The circadian rhythm

Shift work interferes with the body's circadian rhythm - the approximate 24-hour cycle that regulates when we go to sleep and when we wake up, primarily in response to light and dark in the environment.

The body's central circadian rhythm, or "master clock," is made up of around 20,000 nerve cells in the brain, which are collectively referred to as the suprachiasmatic nucleus (SCN).

Situated in the hypothalamus, the SCN receives information about light and dark levels from the retina of the eyes, and this information is sent to the body's cells.

Papagiannakopoulos and colleagues describe two genes within cells that play a role in circadian clock regulation: Bmal1 and Per2.

Bmal1 is responsible for activating Per2. Upon activation, Per2 switches on a number of biological processes regulated by circadian rhythm, including cell division and metabolism, which the team points out are two hallmarks of cancer.

The researchers note that the proteins encoded by these genes usually fluctuate throughout the day, but these fluctuations diminish if light and dark cycles are disrupted.

"Cells need the light cue, which is like a reset button for the clock. When you lose that cue, you lose the normal rhythms in every cell in your body," explains Papagiannakopoulos.

'Jet lag' schedule fueled tumor growth in mice

For their study, the researchers looked at how disruption to light and dark cycles affect Bmal1 and Per2 gene activity, and how this might influence cancer development.

To reach their findings, the team genetically modified mice to develop non-small cell lung cancer, which is a form of lung cancer that accounts for around 80-85 percent of all cases.

The mice were divided into two groups. Each group was exposed to different light/dark schedules, and the team analyzed the rodents' gene activity and tumor growth.

One group of mice was exposed to a normal light/dark schedule, which involved 12 hours of light followed by 12 hours of darkness. The other group followed a "jet lag" schedule, which involved exposure to an extra 8 hours of light every 2-3 days.

The researchers note that the jet lag schedule simulated the circadian rhythm disruption that humans experience when working night shifts or traveling through different time zones.

Compared with mice exposed to the normal light/dark schedule, those exposed to the jet lag schedule experienced faster and more aggressive tumor growth, the team found.

Bmal1, Per2 disruption leads to build-up of cancer-promoting protein

Next, the researchers "knocked out" the Bmal1 and Per2 genes from mice and exposed the rodents to normal light/dark schedules. This, too, led to more rapid tumor growth.

"If you disrupt these genes in every cell of the body, the light cues that you normally receive do not apply," notes Papagiannakopoulos. "It's a way of taking a molecular hammer and just breaking this clock."

The team explains that when these genes are disrupted, c-myc builds up, which triggers a rise in cell metabolism, growth, and division. This can fuel cancer development.

Further supporting their findings, by analyzing human lung tumor samples, the researchers identified significantly lower levels of Bmal1 and Per2 gene expression, as well as lower expression of other genes that regulate circadian rhythm.

The authors say their findings shed light on how shift work and other factors that disrupt the circadian clock may lead to cancer development:

2019 Healthline Media UK Ltd. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.